AzTrials
AzTrials

SleepNCT03074617

Electromagnetic Field Effects of Mobile Communication (LTE) on Sleep in the Context of Genetic Variation

A study testing LTE field in people with Sleep, run by University of Zurich at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The effect of electromagnetic fields of the latest standard in mobile communication (long term evolution, LTE) on sleep is studied in healthy, young individuals. Read more about this study

Who is it for?
Ages 18 to 30 years, men onlyHealthy volunteers can take part
Conditions the study is for
Sleep
What is being tested?
LTE field
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
34 participants
Where
1 siteSwitzerland
Study dates
31 Jan 2017to 30 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 18-30 years
  • German knowledge (reading and writing)
  • Right-handedness
  • Body mass index (BMI) 18.5-25.0 kg/m2
  • Mobile communication (phone calls) less than 2 hours per week
  • Moderate alcohol consumption (less than 5 alcoholic beverages per week)
  • Moderate caffeine consumption (less than 5 caffeinated foods per day, e.g. coke, coffee, energy drinks, green or black tea, chocolate)
  • Informed consent

Who cannot join

  • Travels across more than 2 time zones in the last 30 days or during the study
  • Nocturnal shift work
  • Extreme chronotype or extreme sleep duration (less than 5 hours or more than 10 hours on average)
  • Sleep disorders or problems
  • Severe acute or chronic neurological, mental or general health disorders, which might impair the participant's safety or affect the study's outcome
  • Use of medication (regular or during the study), which might affect the study's outcome
Show all 11Show fewer
  • Recreational drug use
  • Smoking (or other tobacco products)
  • Severe skin allergies
  • Relevant findings in physical examination or during the screening night (e.g. sleep disorders)
  • Participation in an other clinical trial in the last 30 days or during the study

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • University of Zurich, Institute of Pharmacology and Toxicology

    Zurich, 8057

Other trials in Switzerland

About this study

The effect of electromagnetic fields of the latest standard in mobile communication (long term evolution, LTE) on sleep is studied in healthy, young individuals.

Conditions
Sleep
Being tested
LTE field, sham field

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LTE fieldOther

    electromagnetic field of the latest standard in mobile communication (long term evolution, LTE)

  • sham fieldOther

    no electromagnetic field

Study groups in NCT03074617
Study groupRoleWhat they receive
LTE fieldExperimentalNot described
Receives: Other: LTE field
sham fieldSham comparatorNot described
Receives: Other: sham field

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. electroencephalographic power during sleep after LTE exposure

    electroencephalogram (EEG)

    Measured: up to 9 hours (approximately 11 p.m. to 8 a.m.)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Mar 2017
  2. Study start31 Jan 2017
  3. Primary completion30 Sep 2022
  4. Study completion30 Sep 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03074617
Sponsor's protocol ID
LTE-Sleep
Status last verified
Jan 2023
First submitted
23 Feb 2017
Last updated
30 Jan 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Eicher C, Marty B, Achermann P, Huber R, Landolt HP. Reduced subjective sleep quality in people rating themselves as electro-hypersensitive: An observational study. Sleep Med. 2024 Jan;113:165-171. doi: 10.1016/j.sleep.2023.11.029. Epub 2023 Nov 21.

    PubMed 38029625

Questions about this trial

What is this clinical trial studying?

A study testing LTE field in people with Sleep, run by University of Zurich at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

electroencephalographic power during sleep after LTE exposure (time frame: up to 9 hours (approximately 11 p.m. to 8 a.m.)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03074617, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in